Multiple myeloma is the second most common blood cancer, with around 40,000 new cases per year in Europe
News
AbbVie files Rinvoq for psoriatic arthritis
Rinvoq is a selective and reversible JAK inhibitor being studied in several immune-mediated inflammatory diseases
Iterum hit by failure of anti-infective sulopenem
The company is now mulling over its future, which might include sale of the business, restructure, or dissolving and liquidating assets
New US approval for AZ’ Brilinta
New Brilinta indication expands treatment to high-risk coronary patients without a history of stroke or heart attack
PIONEER COVID-19 trial wins funding injection from LifeArc
The funds will enable researchers to investigate the science around the trial, including why coronavirus affects some people more than others
Coronavirus bottleneck leaves 2m waiting for cancer care
2.1 million people are waiting for breast, bowel or cervical screening
Lynparza backed by CHMP for BRCA-mutated pancreatic cancer
Lynparza is the only PARP inhibitor to show patient benefit in a Phase III trial in this setting, says AZ
UK study highlights potential of genetic screening for prostate cancer
Genetic ‘barcoding’ in GP surgeries can identify men at higher risk of prostate cancer, researchers claim
New centre to tackle impact of ethnicity and race on health
The NHS Race and Health Observatory will be hosted by the NHS Confederation
Pfizer’s Ibrance ‘unlikely’ to hit key early breast cancer goal
The trial is unlikely to show a statistically significant improvement in invasive disease-free survival
New vaccine for Ebola among CHMP recommendations
The vaccine could be Janssen’s first to win EU approval
Tagrisso shows ‘unprecedented’ disease free survival in lung cancer
The Phase III ADAURA trial showed treatment with Tagrisso after surgery with curative intent the the risk of disease recurrence or death by around 80%
GSK to make 1bn doses of pandemic vaccine adjuvant
The adjuvant could reduce the amount of vaccine protein required per dose and enhance the immune response
CRUK, Latus and Edinburgh Uni launch test camostat for COVID-19
The treatment for pancreatic inflammation has been shown in the lab to prevent COVID-19 from entering human cells
Roche begins trial of Actemra/RoActemra plus remdesivir
The trial will test the potential of combining an antiviral with an immune modulator
